Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avalo Therapeutics (AVTX) Tax Rate (2017 - 2025)

Historic Tax Rate for Avalo Therapeutics (AVTX) over the last 9 years, with Q3 2025 value amounting to 0.04%.

  • Avalo Therapeutics' Tax Rate rose 200.0% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year decrease of 2600.0%. This contributed to the annual value of 0.33% for FY2024, which is 2800.0% down from last year.
  • According to the latest figures from Q3 2025, Avalo Therapeutics' Tax Rate is 0.04%, which was up 200.0% from 0.08% recorded in Q2 2025.
  • Avalo Therapeutics' 5-year Tax Rate high stood at 1.15% for Q2 2021, and its period low was 0.32% during Q4 2024.
  • For the 5-year period, Avalo Therapeutics' Tax Rate averaged around 0.01%, with its median value being 0.04% (2022).
  • As far as peak fluctuations go, Avalo Therapeutics' Tax Rate plummeted by -90900bps in 2021, and later surged by 2000bps in 2022.
  • Quarter analysis of 5 years shows Avalo Therapeutics' Tax Rate stood at 0.02% in 2021, then crashed by -291bps to 0.08% in 2022, then soared by 235bps to 0.11% in 2023, then plummeted by -394bps to 0.32% in 2024, then soared by 89bps to 0.04% in 2025.
  • Its last three reported values are 0.04% in Q3 2025, 0.08% for Q2 2025, and 0.06% during Q1 2025.